Clinical trial
A Phase III, Multicenter, Single-Arm Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Pediatric Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04958265 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Multicenter, Single-Arm Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Pediatric Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- November 17, 2021
- Completion date
- May 19, 2029
- Enrollment
- 41 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.